Longevity and Cellular Health Research Track
The compounds people research to age slower.
Longevity attracts the biggest promises in the space. This track keeps the focus on what the evidence supports, compound by compound.
Who this is for
Aging biology, mitochondrial health, cellular repair, oxidative stress, energy decline, redox balance.
How this track is graded
Longevity research rewards skepticism. The question is never whether a compound sounds futuristic, it is whether the data supports the claim. This track grades cellular and mitochondrial compounds by exactly that.
Snapshot
| Compound | Tier | What people research it for | What the evidence shows |
|---|---|---|---|
| NAD+ | B | Researched for cellular energy and mitochondrial function. | Mechanistic and early human work. |
| SS-31 | B | Mitochondria-targeted research. | Preclinical and early clinical. |
| MOTS-C | B | Mitochondrial-derived signaling. | Mostly preclinical. |
| Glutathione | B | Redox balance and antioxidant signaling. | Mixed human data by route. |
| Epitalon | C+ | Telomerase and pineal peptide biology. | Sparse and low-quality evidence. |
Pressure Test · Lead compound
NAD+
Mechanism
Cellular coenzyme in energy metabolism.
Evidence
Tier B.
Risk
Research-use-only. Route-dependent.
Standing
Not an approved longevity therapy.
Reading order
Download the Peptide Research Playbook
Stop guessing. Learn how to evaluate peptide claims before you trust them.
Free Peptide Research Playbook on signup. No spam. Unsubscribe anytime.